Search references for MAZDUTIDE. Phrases containing MAZDUTIDE
See searches and references containing MAZDUTIDE!MAZDUTIDE
GLP1 poly-agonist drug
Mazdutide (also known as IBI362 or LY3305677) is a dual agonist of the GLP-1 receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM). The
Mazdutide
Gastrointestinal peptide hormone involved in glucose homeostasis
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Glucagon-like_peptide-1
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Retatrutide
Medication used to treat diabetes
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Metformin
Anti-diabetic and anti-obesity medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Semaglutide
Anti-obesity medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Orforglipron
Diabetes medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Dapagliflozin
Chinese Biopharmaceutical Company
due to Food and Drug Administration rejection. In June 2025, Innovent's Mazdutide was approved in China. It was the first Chinese company to win regulatory
Innovent_Biologics
Anti-diabetic and anti-obesity medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Tirzepatide
Enzyme blocker and diabetes treatment drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Dipeptidyl peptidase-4 inhibitor
Dipeptidyl_peptidase-4_inhibitor
Diabetes medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Empagliflozin
Combination drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_icodec/semaglutide
Pharmaceutical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Brenipatide
Long-acting insulin
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_glargine
Receptor activated by peptide hormone GLP-1
glepaglutide apraglutide maridebart cafraglutide tirzepatide pegapamodutide mazdutide survodutide bamadutide pemvidutide cotadutide retatrutide Lithium chloride
Glucagon-like peptide-1 receptor
Glucagon-like_peptide-1_receptor
Class of drugs used to treat diabetes
effects have hampered development. The most advanced of these drugs is mazdutide which is in a phase III trial as of 2023. Following the discovery of GLP-1/GIP
GLP1_poly-agonist_peptides
Pharmaceutical drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sitagliptin/metformin
Class of organic compounds used in medicine and agriculture
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sulfonylurea
Diabetes medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sitagliptin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Pioglitazone
Class of medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
SGLT2_inhibitor
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Enavogliflozin
Drugs that lower blood glucose levels to treat diabetes
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Diabetes_medication
Ultralong-acting basal insulin analogue
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_degludec
Pharmaceutical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Conveglipron
Anti-diabetic medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Liraglutide
Diabetes medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Dulaglutide
Use of insulin protein and analogs as medical treatment
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_(medication)
Oral anti-diabetic drugs
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Alpha-glucosidase_inhibitor
Drug used for the treatment of symptoms of metabolic syndrome
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
PPAR_agonist
Medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Exenatide
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Acarbose
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Saxagliptin
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
List of commercially available insulins
List_of_commercially_available_insulins
Intermediate acting insulin formulation
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
NPH_insulin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Retagliptin
Pharmaceutical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
CT-868
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Biguanide
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Linagliptin
Alpha-glucosidase inhibitor
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Voglibose
Rapid-acting man-made insulin
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_aspart
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sergliflozin_etabonate
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Glipizide
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Fidarestat
Ultralong-acting basal insulin analogue
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_icodec
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Glibenclamide
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sotagliflozin
Rapid-acting insuline analog
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_lispro
Cellular therapy medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Donislecel
Antidiabetic medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Bexagliflozin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Gliclazide
Class of chemical compounds
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Thiazolidinedione
Pharmaceutical drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Empagliflozin/linagliptin
Pharmaceutical drug classification
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
ATC_code_A10
Pharmaceutical drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Empagliflozin/metformin
Anti-diabetic drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Alogliptin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Canagliflozin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sorbinil
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Buformin
Dopamine agonist medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Bromocriptine
Diabetes drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Lixisenatide
Historical formulation of insulin as medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Lente_insulin
Medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_efsitora_alfa
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Danuglipron
Combination drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Empagliflozin/linagliptin/metformin
Empagliflozin/linagliptin/metformin
Combination medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin degludec/insulin aspart
Insulin_degludec/insulin_aspart
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Troglitazone
Rapid-acting insulin analogue
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_glulisine
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Vildagliptin
Pharmaceutical drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Albiglutide
Long-acting form of insulin
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Ultralente_insulin
Medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Dasiglucagon
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Repaglinide
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Rosiglitazone
Medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Glimepiride
Investigational substance-related disorder drugs
STP-7) – metabotropic glutamate mGlu5 receptor antagonist – alcoholism Mazdutide (IBI-362; LY-3305677; OXM-3) – glucagon-like peptide-1 (GLP-1) receptor
List of investigational substance-related disorder drugs
List_of_investigational_substance-related_disorder_drugs
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Lotiglipron
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Rivoglitazone
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Saroglitazar
Modified forms of synthetic insulin
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_analogue
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Ciglitazone
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Nateglinide
results of health and medical research are reported: phase 2-trialed Mazdutide against type-2 diabetes (9 Nov), phase 1-trialed lepodisiran against cardiovascular
2023_in_science
Diabetes medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Pramlintide
Investigational sleep apnea drugs
antagonist/anticholinergic) and atomoxetine (norepinephrine reuptake inhibitor) [1], Mazdutide (IBI-362; LY-3305677; OXM-3) – glucagon-like peptide-1 (GLP-1) receptor
List of investigational sleep apnea drugs
List_of_investigational_sleep_apnea_drugs
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Epalrestat
Chemical substance
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Meglitinide
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Ertugliflozin
Powdered insulin delivered with an inhaler
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Inhalable_insulin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Gemigliptin
Two drugs combined to treat diabetes
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Dapagliflozin/metformin
Combination drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Sitagliptin/simvastatin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Miglitol
Pharmaceutical drug
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_degludec/liraglutide
Short-acting insulin formulation
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Regular_insulin
Medication
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Velagliflozin
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Trelagliptin
Long-acting man-made insulin
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Insulin_detemir
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Lobeglitazone
Chemical compound
Lixisenatide Orforglipron Semaglutide Taspoglutide† GLP1 poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP) DPP-4
Remogliflozin_etabonate
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE
MAZDUTIDE